Integra LifeSciences Holdings CorporationIARTNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
3Y CAGR-42.5%
5Y CAGR-24.4%
Year-over-Year Change
Cash generated from core business operations
3Y CAGR
-42.5%/yr
vs +7.3%/yr prior
5Y CAGR
-24.4%/yr
Recent deceleration
Acceleration
-49.7pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.2x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $50.38M | -61.1% |
| 2024 | $129.38M | -7.6% |
| 2023 | $139.96M | -47.1% |
| 2022 | $264.47M | -15.4% |
| 2021 | $312.43M | +53.3% |
| 2020 | $203.83M | -11.9% |
| 2019 | $231.43M | +15.9% |
| 2018 | $199.68M | +74.3% |
| 2017 | $114.54M | -1.6% |
| 2016 | $116.41M | - |